These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

872 related items for PubMed ID: 12214145

  • 1. General haemostatic agents--fact or fiction?
    Hedner U.
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145
    [Abstract] [Full Text] [Related]

  • 2. New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa.
    Veldman A, Hoffman M, Ehrenforth S.
    Curr Med Chem; 2003 May; 10(10):797-811. PubMed ID: 12678684
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. To general haemostasis--the evidence-based route.
    Erhardtsen E.
    Pathophysiol Haemost Thromb; 2002 May; 32 Suppl 1():47-52. PubMed ID: 12214148
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mechanism of action, development and clinical experience of recombinant FVIIa.
    Hedner U.
    J Biotechnol; 2006 Aug 05; 124(4):747-57. PubMed ID: 16697480
    [Abstract] [Full Text] [Related]

  • 8. First 20 years with recombinant FVIIa (NovoSeven).
    Hedner U, Lee CA.
    Haemophilia; 2011 Jan 05; 17(1):e172-82. PubMed ID: 20609014
    [Abstract] [Full Text] [Related]

  • 9. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
    Tomokiyo K, Nakatomi Y, Araki T, Teshima K, Nakano H, Nakagaki T, Miyamoto S, Funatsu A, Iwanaga S.
    Vox Sang; 2003 Nov 05; 85(4):290-9. PubMed ID: 14633255
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mechanism of action of factor VIIa in the treatment of coagulopathies.
    Hedner U.
    Semin Thromb Hemost; 2006 Apr 05; 32 Suppl 1():77-85. PubMed ID: 16673269
    [Abstract] [Full Text] [Related]

  • 13. Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI.
    Livnat T, Zivelin A, Martinowitz U, Salomon O, Seligsohn U.
    J Thromb Haemost; 2006 Jan 05; 4(1):192-200. PubMed ID: 16409469
    [Abstract] [Full Text] [Related]

  • 14. Thrombin generation and platelet activation induced by rFVIIa (NovoSeven) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions.
    Aljamali MN, Kjalke M, Hedner U, Ezban M, Tranholm M.
    Haemophilia; 2009 Nov 05; 15(6):1318-26. PubMed ID: 19659796
    [Abstract] [Full Text] [Related]

  • 15. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII.
    Hoffman M, Monroe DM, Roberts HR.
    Blood Coagul Fibrinolysis; 1998 Mar 05; 9 Suppl 1():S61-5. PubMed ID: 9819030
    [Abstract] [Full Text] [Related]

  • 16. High dose factor VIIa improves clot structure and stability in a model of haemophilia B.
    Wolberg AS, Allen GA, Monroe DM, Hedner U, Roberts HR, Hoffman M.
    Br J Haematol; 2005 Dec 05; 131(5):645-55. PubMed ID: 16351642
    [Abstract] [Full Text] [Related]

  • 17. Factor VIIa and its potential therapeutic use in bleeding-associated pathologies.
    Hedner U.
    Thromb Haemost; 2008 Oct 05; 100(4):557-62. PubMed ID: 18841276
    [Abstract] [Full Text] [Related]

  • 18. Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high-responding inhibitors--a thrombin generation-guided pilot study.
    Livnat T, Martinowitz U, Azar-Avivi S, Zivelin A, Brutman-Barazani T, Lubetsky A, Kenet G.
    Haemophilia; 2013 Sep 05; 19(5):782-9. PubMed ID: 23659442
    [Abstract] [Full Text] [Related]

  • 19. NovoSeven as a universal haemostatic agent.
    Hedner U.
    Blood Coagul Fibrinolysis; 2000 Apr 05; 11 Suppl 1():S107-11. PubMed ID: 10850574
    [Abstract] [Full Text] [Related]

  • 20. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
    Hoffman M, Monroe DM.
    Dis Mon; 2003 Jan 05; 49(1):14-21. PubMed ID: 12525825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.